EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Surgical Management of Zollinger‐Ellison Syndrome in Multiple Endocrine Neoplasia Type 1 an AFCE and GTE Cohort Study. (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines)

Sébastien Gaujoux, François Pattou, Guillaume Cadiot, Mustapha Adham, Philippe Bachellier, Jean-Pierre Bail, Robert Caiazzo, Nicolas Carrere, Philippe Chaffanjon, Sophie Deguelte, Gianluca Donatini, Bertrand Dousset und 16 weitere

World Journal of Surgery · 2026-05 · 50 (5) · 1300-1311

DOI: 10.1002/wjs.70303 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift World Journal of Surgery, online erschienen am 20.03.2026. Verfasst von Sébastien Gaujoux und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral, and Endocrine Surgery, Pitié Salpêtrière Hospital, AP-HP, Paris, France. Hauptthemen laut MEDLINE: Zollinger-Ellison Syndrome, Multiple Endocrine Neoplasia Type 1, Gastrinoma, Pancreatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To describe surgical indications, procedures and outcomes in patients operated for Zollinger‐Ellison syndrome (ZES) in multiple endocrine neoplasia type 1 (MEN1) using a large nationwide cohort.

Background

Management of ZES in MEN1 remains controversial.

Methods

All patients with ZES diagnosed through the MEN1 AFCE/GTE network from 1985 to 2015.

Results

Among 233 ZES patients, 66 (28%) were operated for ZES‐related gastrinomas. Thirty‐three (51%) procedures aimed to remove gastrinomas and associated pancreatic neuroendocrine tumors (pNET(s)) with appropriate resection. Thirty‐two procedures (49%) aimed to remove gastrinomas alone (ZES group). Survival was decreased in patients metastatic at ZES diagnosis ( p < 0.001). Fifteen‐year survival among non‐metastatic patients was not significantly better in operated patients (82% vs. 70%, p = 0.2). Perioperative mortality was nil. Metastatic lymph nodes were found in 30/42 lymphadenectomies (71%). The choice between pancreaticoduodenectomy versus duodenal focused surgery in the ZES group was associated with pre‐operative detection of adenopathies ( p > 0.001), leading to more frequent lymphadenectomies ( p < 0.01). Previous pancreatic surgeries (30%) may have influenced the choice of ZES procedures. Gastrin levels were more frequently normalized when the duodenum and the head of pancreas were removed versus more localized duodenal surgeries ( p < 0.01).

Conclusion

The high rate of invaded nodes in lymphadenectomies in MEN1 patients operated for ZES, the absence of operative mortality, and the decreased survival in metastatic patients are indirect arguments for surgery. Pancreaticoduodenectomy may be indicated in young and fit individuals to better control hypergastrinemia and to prevent metastatic progression in the ZES group. Gastrinoma removal is justified when associated with large pNETs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zollinger-Ellison SyndromeMultiple Endocrine Neoplasia Type 1GastrinomaPancreatic NeoplasmsHumansMaleFemaleMiddle AgedAdultCohort StudiesTreatment OutcomeAgedPancreaticoduodenectomyRetrospective StudiesFranceYoung AdultAdolescentPancreatectomyLymph Node Excision

Stichwörter der Autor:innen

Zollinger‐Ellison syndromeduodenotomygastrinomamultiple endocrine neoplasia type 1pancreaticoduodenectomy

Autor:innen und Institutionen

  • Department of General, Visceral, and Endocrine Surgery, Pitié Salpêtrière Hospital, AP-HP, Paris, France.
  • Department of General and Endocrine Surgery, Lille University Hospital, Lille, France.
  • Department of Hepato-Gastro-Enterology, Robert-Debré Hospital, Reims-Champagne-Ardennes University, Reims, France.
  • Department of Digestive Surgery, Lyon Sud Faculty of Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1 (UCBL1), Lyon, France.
  • Department of HPB Surgery and Liver Transplant, Hautepierre Hospital, Strasbourg University, Strasbourg, France.
  • Department of Digestive Surgery, Brest University Hospital, Brest, France.

ORCID-Profile: Laurent Sulpice, Pierre Goudet

Zitieren

APA

Gaujoux, S., Pattou, F., Cadiot, G., Adham, M., Bachellier, P., Bail, J. P., Caiazzo, R., Carrere, N., Chaffanjon, P., Deguelte, S., Donatini, G., Dousset, B., Faron, M., Gronnier, C., Heyd, B., Lifante, J. C., Lubrano, J., Meurisse, N., Mirallié, E., …, & Goudet, P. (2026). Surgical Management of Zollinger‐Ellison Syndrome in Multiple Endocrine Neoplasia Type 1 an AFCE and GTE Cohort Study. (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines). World Journal of Surgery, 50(5), 1300-1311. https://doi.org/10.1002/wjs.70303

Vancouver

Gaujoux S, Pattou F, Cadiot G, Adham M, Bachellier P, Bail JP, et al. Surgical Management of Zollinger‐Ellison Syndrome in Multiple Endocrine Neoplasia Type 1 an AFCE and GTE Cohort Study. (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines). World Journal of Surgery. 2026;50(5):1300-1311. doi:10.1002/wjs.70303

BibTeX
@article{Gaujoux2026,
  author = {Gaujoux, Sébastien and Pattou, François and Cadiot, Guillaume and Adham, Mustapha and Bachellier, Philippe and Bail, Jean-Pierre and Caiazzo, Robert and Carrere, Nicolas and Chaffanjon, Philippe and Deguelte, Sophie and Donatini, Gianluca and Dousset, Bertrand and Faron, Matthieu and Gronnier, Caroline and Heyd, Bruno and Lifante, Jean-Christophe and Lubrano, Jean and Meurisse, Nicolas and Mirallié, Eric and Santucci, Nicolas and Sauvanet, Alain and Sebag, Frédéric and Sulpice, Laurent and Thebault, Baudoin and Tuech, Jean-Jacques and Walter, Thomas and Binquet, Christine and Goudet, Pierre},
  title = {Surgical Management of Zollinger‐Ellison Syndrome in Multiple Endocrine Neoplasia Type 1 an AFCE and GTE Cohort Study. (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines)},
  journal = {World Journal of Surgery},
  year = {2026},
  volume = {50},
  number = {5},
  pages = {1300--1311},
  doi = {10.1002/wjs.70303}
}
Kostenlos starten →